REVANCE THERAPEUTICS INC shareholders Q2 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 216 filers reported holding REVANCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

REVANCE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Tower Research Capital LLC (TRC) 3,273$82,8400.00%
AMALGAMATED BANK 12,583$3180.00%
Elequin Capital, LP 264$6,6820.00%
Russell Investments Group, Ltd. 58,675$1,485,0620.00%
Capital Advisors, Ltd. LLC 760$190.00%
VANGUARD GROUP INC 4,652,776$117,761,7610.00%
FIRST TRUST ADVISORS LP 108,916$2,756,6630.00%
Calamos Advisors LLC 24,923$630,8010.00%
Bank of New York Mellon Corp 372,509$9,428,2030.00%
MORGAN STANLEY 639,756$16,192,2260.00%
Cubist Systematic Strategies, LLC 13,000$329,0300.00%
Handelsbanken Fonder AB 13,500$3420.00%
Ensign Peak Advisors, Inc 37,000$936,4700.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 15,461$391,3180.00%
Mirae Asset Global Investments Co., Ltd. 37,731$954,9720.00%
Leucadia National 8,166$206,6810.00%
AMERIPRISE FINANCIAL INC 213,116$5,393,9660.00%
Squarepoint Ops LLC 32,206$815,1340.00%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 15,252$3860.00%
Citadel Advisors 121,400$3,072,6340.00%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q2 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.